4
Changes in Ownership
RESMED INC Filed Acc 0001127602-22-025832
President and COO sold 11,280 shares at $222.07 ($2,504,939)
- President and COO acquired 18,032 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Douglas Robert Andrew President and COO | 2022-11-15 | Option exercise | +1,144 | $58.24 | $66,627 | 34,578 | D |
| Douglas Robert Andrew President and COO | 2022-11-15 | Option exercise | +16,888 | $58.24 | $983,557 | 51,466 | D |
| Douglas Robert Andrew President and COO | 2022-11-15 | Sale | −11,280 | $222.07 | $2,504,939 | 40,186 | D |
| Derivatives | |||||||
| Douglas Robert Andrew President and COO | 2022-11-15 | Option exercise · ResMed Common Stock Options | −1,144 | 16,888 | D | ||
| Douglas Robert Andrew President and COO | 2022-11-15 | Option exercise · ResMed Common Stock Options | −16,888 | 0 | D | ||
| Open-market sales · 11,280 sh · avg $222.07 · $2,504,939 | |||||||
Loading xslF345X03/form4.xml…